Cited by 24Dermatology and Skin DiseasesContact Dermatitis and AllergiesAdvancements in Transdermal Drug Delivery

Recent advances in understanding the role of the skin microbiome in the treatment of atopic dermatitis

Open access
Kim, Kyunghee, Jang, Hyeji, Kim, Eunyul, Kim, Hyeju, Sung, Gun Yong·2023·Experimental Dermatology

Abstract

The skin is the largest organ in the human body, and histologically consists of the epidermis, dermis and subcutaneous tissue. Humans maintain a cooperative symbiotic relationship with their skin microbiota, a complex community of bacteria, fungi and viruses that live on the surface of the skin, and which act as a barrier to protect the body from the inside and outside. The skin is a ‘habitat’ and vast ‘ecosystem’ inhabited by countless microbes; as such, relationships have been forged through millions of years of coevolution. It is not surprising then that microbes are key participants in shaping and maintaining essential physiological processes. In addition to maintaining barrier function, the unique symbiotic microbiota that colonizes the skin increases the immune response and provides protection against pathogenic microbes. This review examines our current understanding of skin microbes in shaping and enhancing the skin barrier, as well as skin microbiome–host interactions and their roles in skin diseases, such as atopic dermatitis (AD). We also report on the current status of AD therapeutic drugs that target the skin microbiome, related research on current therapeutic strategies, and the limitations and future considerations of skin microbiome research. In particular, as a future strategy, we discuss the need for a skin‐on‐a‐chip‐based microphysiological system research model amenable to biomimetic in vitro studies and human skin equivalent models, including skin appendages.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/exd.14940

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent therapies, such as dupilumab and tralokinumab, favor skin microbiota rebalancing in patients with AD.

    “Recent therapies, such as dupilumab and tralokinumab, favor skin microbiota rebalancing in patients with AD.94, 105”

    From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [94]

    Section 8 discusses therapies intended to restore a healthy skin microbiome in patients with atopic dermatitis, but does not identify dupilumab or tralokinumab as doing so. Searches for each drug name found no passage addressing its effect on skin microbiota; the general discussion does not establish the claim about these therapies. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 145 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. [54]54. Chen YE, Fischbach MA, Belkaid Y. Skin microbiota-host interac- tions. Nature. 2018;553(7689):427-436.
  2. [61]61. David Boothe W, Tarbox JA, Tarbox MB. Atopic dermatitis: patho- physiology. Adv Exp Med Biol. 2017;1027:21-37.
  3. [69]69. Hon K, Tsang Y, Pong N, Leung T, Ip M. Exploring Staphylococcus epidermidis in atopic eczema: friend or foe? Clin Exp Dermatol. 2016;41(6):659-663.

Cited by

Sorted by citations

Authors
Kim, K., Jang, H., Kim, E., Kim, H., & Sung, G. Y.
Affiliations
  • Interdisciplinary Program of Nano‐Medical Device Engineering Hallym University Chuncheon Korea
  • Hallym University (KR)
Corresponding author
Sung, Gun Yong
Venue
Experimental Dermatology
Publisher
Wiley
Published
2023-09-28
Volume
32
Issue
12
Pages
2048-2061
ISSN
  • 0906-6705 (ISSN-L)
  • 1600-0625
OpenAlex
W4387114314
Cited by
24
References
145
Citations by year
2026: 6 · 2025: 10 · 2024: 7 · 2023: 1
FWCI
1.10
Type
journal article
Language
en
Open access
Locations
  • Experimental Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministry of Science, ICT and Future Planning ((NRF‐ 2020R1A2C2009928))
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
skin microbiome, atopic dermatitis, skin barrier function, microbiota-host interactions, skin diseases, microbiome-targeted therapy, skin-on-a-chip, skin appendages, symbiosis
MeSH terms
Dermatitis, Atopic, Epidermis, Humans, Skin, Skin Diseases, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review